前收市價 | 26.80 |
開市 | 26.80 |
買盤 | 14.85 |
賣出價 | 16.75 |
拍板 | 180.00 |
到期日 | 2025-01-17 |
今日波幅 | 26.80 - 26.80 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 1k |
AbbVie (ABBV) closed the most recent trading day at $170.46, moving +0.61% from the previous trading session.
Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.